A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study

被引:12
作者
Holmberg, L. [1 ,2 ,4 ]
Robinson, D. [3 ]
Sandin, F. [4 ]
Bray, F. [5 ,6 ,7 ]
Linklater, K. M. [3 ]
Klint, A. [8 ]
Lambert, P. C. [9 ,10 ]
Adolfsson, J. [11 ]
Hamdy, F. C. [12 ]
Catto, J. [13 ]
Moller, H. [1 ,3 ]
机构
[1] Kings Coll London, Sch Med, Div Canc Studies, Sect Canc Epidemiol, London SE1 9RT, England
[2] Uppsala Univ, Dept Surg Sci, Univ Uppsala Hosp, S-75185 Uppsala, Sweden
[3] Kings Coll London, Thames Canc Registry, London SE1 3QD, England
[4] Univ Uppsala Hosp, Reg Oncol Ctr, S-75185 Uppsala, Sweden
[5] Canc Registry Norway, Dept Registry Based Res, Oslo, Norway
[6] Int Agcy Res Canc, Canc Informat Sect, F-69372 Lyon 08, France
[7] Canc Registry Norway, Dept Clin & Registry Based Res, Oslo, Norway
[8] Natl Board Hlth & Welf, Swedish Canc Registry, S-10630 Stockholm, Sweden
[9] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England
[10] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
[11] Karolinska Inst, CLINTEC Dept, Karolinska Univ Hosp S3 00, Ctr Oncol, S-17176 Stockholm, Sweden
[12] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England
[13] Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England
关键词
Prostate cancer; Survival analysis; Public health practice; Excess mortality; Cancer registries; TRENDS; UK; MORTALITY; TIME;
D O I
10.1016/j.canep.2011.08.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The objective of the study was to compare patterns of survival 2001-2004 in prostate cancer patients from England, Norway and Sweden in relation to age and period of follow-up. Subjects and methods Excess mortality in men with prostate cancer was estimated using nation-wide cancer register data using a period approach for relative survival. 179,112 men in England, 23,192 in Norway and 59,697 in Sweden were included. Results In all age groups, England had the lowest survival, particularly so among men aged 80+. Overall age-standardised five-year survival was 76.4%, 80.3% and 83.0% for England, Norway and Sweden, respectively. The majority of the excess deaths in England were confined to the first year of follow-up. Conclusion The results indicate that a small but important group of older patients present at a late stage and succumb early to their cancers, possibly in combination with severe comorbidity, and this situation is more common in England than in Norway or Sweden. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E7 / E12
页数:6
相关论文
共 23 条
  • [1] What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
    Abdel-Rahman, M.
    Stockton, D.
    Rachet, B.
    Hakulinen, T.
    Coleman, M. P.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 : S115 - S124
  • [2] Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
    Adolfsson, Jan
    Garmo, Hans
    Varenhorst, Eberhard
    Ahlgren, Goran
    Ahlstrand, Christer
    Andren, Ove
    Bill-Axelson, Anna
    Bratt, Ola
    Damber, Jan-Erik
    Hellstrom, Karin
    Hellstrom, Magnus
    Holmberg, Erik
    Holmberg, Lars
    Hugosson, Jonas
    Johansson, Jan-Erik
    Petterson, Bill
    Tornblom, Magnus
    Widmark, Anders
    Stattin, Par
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (06): : 456 - 477
  • [3] [Anonymous], 2005, STAT STAT SOFTW REL
  • [4] Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Berrino, Franco
    De Angelis, Roberta
    Sant, Milena
    Rosso, Stefano
    Lasota, Magdalena B.
    Coebergh, Jan W.
    Santaquilani, Mariano
    [J]. LANCET ONCOLOGY, 2007, 8 (09) : 773 - 783
  • [5] Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006
    Bray, Freddie
    Klint, Asa
    Gislum, Mette
    Hakulinen, Timo
    Engholm, Gerda
    Tryggvadottir, Laufey
    Storm, Hans H.
    [J]. ACTA ONCOLOGICA, 2010, 49 (05) : 644 - 654
  • [6] Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO
  • [7] 2-#
  • [8] Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study
    Collin, Simon M.
    Martin, Richard M.
    Metcalfe, Chris
    Gunnell, David
    CAlbertsen, Peter
    Neal, David
    Hamdy, Freddie
    Stephens, Peter
    Lane, J. Athene
    Moore, Rollo
    Donovan, Jenny
    [J]. LANCET ONCOLOGY, 2008, 9 (05) : 445 - 452
  • [9] Standard cancer patient population for age standardising survival ratios
    Corazziari, I
    Quinn, M
    Capocaccia, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) : 2307 - 2316
  • [10] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
    Draisma, G
    Boer, R
    Otto, SJ
    van der Cruijsen, IW
    Damhuis, RAM
    Schröder, FH
    de Koning, HJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) : 868 - 878